News
-
DIY micro-needling
Thursday | Oct 17 2024CONSUMERS can now enjoy at-home microneedling with the new Dermapen HOME ($749), designed to complement the clinical cosmetic procedure in between appointments to maintain results.
-
QLD digital pact
Thursday | Oct 17 2024HEALTHCARE ICT innovator Vitalis Solutions has formed a partnership with technology company Servita to drive large-scale transformation projects in the state's health sector.
-
Treating eczema
Thursday | Oct 17 2024LEO Pharma's delgocitinib cream has launched in Germany, for those suffering chronic hand eczma (CHE), with the European country becoming the first to make the topical cream available.
-
New cancer trials
Thursday | Oct 17 2024ALMOST $22 million will be handed out by the Australian Government to support cancer clinical trials over the next three years.
-
Dispensary Corner 17 Oct 24
Thursday | Oct 17 2024NEXT time you see City of Sydney street cleaners in action, you'll know the water being used has also helped to provide life-saving medical treatment.
-
Amcal enters a new ‘for you, for life’ era
Wednesday | Oct 16 2024AMCAL has unveiled a new brand campaign under the new tagline 'Amcal.
-
DDS on “solid ground”
Wednesday | Oct 16 2024DISCOUNT Drug Stores (DDS) is preparing to launch more than 220 private and exclusive label products into its stores over the next six months, the brand revealed at its annual conference on the Gold Coast over the weekend.
-
More support for NSW pharmacists
Wednesday | Oct 16 2024THE Pharmaceutical Society of Australia (PSA) has partnered with NSW Health to deliver specialised training and support for pharmacists delivering services under the Opioid Treatment Program (OTP).
-
Have your say
Wednesday | Oct 16 2024ON National Pharmacy Technicians and Assistants Day yesterday (PD 15 Oct), Advanced Pharmacy Australia (AdPha) opened up consultation for Australasia's first competency standards for pharmacy technicians.
-
Combined jab
Wednesday | Oct 16 2024A combined COVID-19 and flu vaccine is being developed in Australia, with researchers at Mater Hospital Brisbane leading the trial.
